Back
ESC Premium Access

Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction +/- heart failure in epirubicinum recipients for bladder cancer

Session: Poster session 5 - Chronic heart failure (CHF)
Topic: Cardiotoxicity of drugs
Speaker: Associate Professor A. Tase (Pitesti, RO)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Adrian Tase

Emergency County Hospital Pitesti Arges, Pitesti (Romania)
1 follower

31 more presentations in this session

Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling.

Speaker: Doctor C. Santos-Gallego (New York, US)

Access
Abstract
Like
Thumbnail

Iron status, respiratory muscle strength, and physical fitness in men with heart failure with reduced ejection fraction

Speaker: Doctor M. Drozd (Wroclaw, PL)

Access
Abstract
Like
Thumbnail

Glycer-AGEs is associated with the severity of cardiac function of diabetic cardiomyopathy(DbCM).

Speaker: Assistant Professor H. Aoki (Uchinada, JP)

Access
Abstract
Like
Thumbnail

Early, combined heart failure therapy attenuates doxorubicin cardiomyopathy in rats

Speaker: Miss M. Lodi (Debrecen, HU)

Access
Abstract
Slides
Like
Thumbnail

Left ventricular torsion and rigid body rotation pattern in patients treated with anthracycline

Speaker: Professor A. Capucci (Ancona, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 5 - Chronic heart failure (CHF)

Speakers: Associate Professor A. Tase, Doctor C. Santos-Gallego, Doctor M. Drozd, Assistant Professor H. Aoki, Miss M. Lodi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources